|Day Low/High||232.83 / 237.33|
|52 Wk Low/High||224.02 / 281.16|
Short position Stryker is being taken to the woodshed again. Down another -$9/share. Here's the bear case.
I am short Stryker . Credit Suisse and others on Wall Street seems to be coming towards my view on MAKO sales and a slowing growth rate for the company: Health Care Earnings Revising Estimates to Reflect Push of Robot Installs Into Q2, FX and Mgm...
Here's what direction this medical device stock is about break.
My Stryker short started poorly. But it has certainly started to improve recently. Small-sized, though I wish it was larger and I hadn't covered any of my short. Here's the bear case.
* The market (and money) never sleeps - and neither do I, it appears! * Futures had a very weak evening/early morning reflecting the China lockdowns, and not deepening concerns over Fed tightening as I suggested on Friday "Workin' on our night moves...
Stryker is trading lower in sympathy with Intuitive Surgical - trading lower on disappointing earnings.
* My revised levels I don't want there to be any ambiguity about the size of my positions, or about my buy and short levels, as I strive for as much transparency as possible. This column is a continued commitment towards that sort of disclosure. "Wh...
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
Robots can't catch Covid-19, or anything else. While the rest of us stay home, they can keep factory output going with a minimum of human intervention.
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
Look for weaknesses in companies like these that can provide solutions to today's pressing issues.
The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.
If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.
Top picks in the fast-growing medical products market.
And as the semiconductor sector continues to shine, Brooks Automation is a name to keep in mind.
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.